title: Caloric restriction attenuates amyloid deposition in middle-aged dtg APP/PS1 mice.
abstract: Caloric restriction (CR) mitigates neurological damage arising from aging and a variety of other sources, including neuropathology in young adult mice that express single and double transgenic (tg) mutations associated with Alzheimer disease (AD). To evaluate the potential of CR to protect against relatively heavy AD-type pathology, middle-aged (13-14-month-old) mice that co-express two mutations related to familial AD, amyloid precursor protein (APP) and presenilin 1 (PS1), were fed balanced diets with 40% fewer calories than ad libitum-fed controls. Following 18 weeks of treatment, mice were killed and brains were processed for quantification of total volume of amyloid-beta (Abeta) in the hippocampal formation and the overlying neocortex. Computerized stereology confirmed that CR reduced the total Abeta volume by about one-third compared to that in age-matched controls. Thus, CR appears to attenuate the accumulation of AD-type neuropathology in two cortical brain regions of middle-aged dtg APP/PS1 mice. These findings support the view that CR could be a potentially effective, non-pharmacology strategy for reducing relatively heavy Abeta deposition in older adult dtg APP/PS1 mice, and possibly afford similar protection against the onset and progression of AD in older adult humans.
authors.affiliation: Laboratory of Experimental Gerontology, Gerontology Research Center, National Institute on Aging, Baltimore, MD 21224, United States. Moutonpe@mail.nih.gov
authors.forename: Peter R
authors.initials: PR
authors.lastname: Mouton
authors.forename: Mark E
authors.initials: ME
authors.lastname: Chachich
authors.forename: Christopher
authors.initials: C
authors.lastname: Quigley
authors.forename: Edward
authors.initials: E
authors.lastname: Spangler
authors.forename: Donald K
authors.initials: DK
authors.lastname: Ingram
mesh_terms: D000375:Aging / Q000378:metabolism*; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D000818:Animals; D031204:Caloric Restriction; D006624:Hippocampus / Q000378:metabolism*; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D019579:Neocortex / Q000378:metabolism*
chemical_list: D016229:Amyloid beta-Peptides
references.citation: Neuroscience. 2005;130(3):667-84
references.pmid: 15590151
references.citation: Neurobiol Aging. 2006 Nov;27(11):1694-704
references.pmid: 16256248
references.citation: BMJ. 2005 Aug 20;331(7514):455; author reply 455
references.pmid: 16110085
references.citation: Science. 2004 Sep 3;305(5689):1423-6
references.pmid: 15353793
references.citation: JAMA. 2000 Mar 22-29;283(12):1571-7
references.pmid: 10735393
references.citation: Ann N Y Acad Sci. 2000 Apr;903:335-44
references.pmid: 10818523
references.citation: J Neurosci. 2008 Dec 17;28(51):13805-14
references.pmid: 19091971
references.citation: Ann Neurol. 1990 May;27(5):457-64
references.pmid: 2360787
references.citation: Milbank Q. 1990;68(2):267-89
references.pmid: 2233632
references.citation: Neurobiol Dis. 2005 Apr;18(3):602-17
references.pmid: 15755686
references.citation: J Neurol Sci. 2004 Nov 15;226(1-2):31-3
references.pmid: 15537515
references.citation: J Neurochem. 2002 Feb;80(3):539-47
references.pmid: 11905999
references.citation: Neurobiol Aging. 1998 Sep-Oct;19(5):371-7
references.pmid: 9880038
references.citation: Arch Neurol. 2004 May;61(5):802-3; author reply 803
references.pmid: 15148166
references.citation: Neuron. 1996 Nov;17(5):1005-13
references.pmid: 8938131
references.citation: Behav Genet. 1999 May;29(3):177-85
references.pmid: 10547924
references.citation: Nutrition. 1989 May-Jun;5(3):155-71; discussion 172
references.pmid: 2520283
references.citation: J Comp Neurol. 2005 May 23;486(1):39-47
references.pmid: 15834963
references.citation: Arch Biochem Biophys. 1996 Sep 1;333(1):189-97
references.pmid: 8806770
references.citation: Neurobiol Dis. 1999 Aug;6(4):231-44
references.pmid: 10448051
references.citation: Neurobiol Dis. 2000 Aug;7(4):321-31
references.pmid: 10964604
references.citation: Am J Pathol. 2001 Mar;158(3):1173-7
references.pmid: 11238065
references.citation: J Chem Neuroanat. 2007 Nov;34(3-4):102-7
references.pmid: 17658239
references.citation: Science. 1992 Apr 10;256(5054):184-5
references.pmid: 1566067
references.citation: Gerontology. 1982;28(4):233-41
references.pmid: 7117847
references.citation: Neurobiol Aging. 2004 Mar;25(3):333-40
references.pmid: 15123339
references.citation: APMIS. 1988 May;96(5):379-94
references.pmid: 3288247
references.citation: Nat Med. 1998 Jan;4(1):97-100
references.pmid: 9427614
references.citation: FASEB J. 2005 Apr;19(6):659-61
references.pmid: 15650008
references.citation: Neuroreport. 2002 Mar 25;13(4):455-9
references.pmid: 11930160
references.citation: Nutr Rev. 2007 Sep;65(9):412-5
references.pmid: 17958208
references.citation: Curr Opin Clin Nutr Metab Care. 2008 Nov;11(6):686-92
references.pmid: 18827571
references.citation: Neuron. 1997 Oct;19(4):939-45
references.pmid: 9354339
references.citation: Exp Gerontol. 2000 May;35(3):299-305
references.pmid: 10832051
references.citation: J Nutr Biochem. 2005 Mar;16(3):129-37
references.pmid: 15741046
references.citation: Neurobiol Aging. 2008 Nov;29(11):1680-9
references.pmid: 17524525
references.citation: Ann N Y Acad Sci. 2004 Jun;1019:412-23
references.pmid: 15247056
references.citation: Neuroreport. 2005 Jul 13;16(10):1055-9
references.pmid: 15973147
references.citation: Exp Neurol. 2002 Feb;173(2):183-95
references.pmid: 11822882
references.citation: Nutr Neurosci. 2003 Jun;6(3):153-62
references.pmid: 12793519
references.citation: Neuroreport. 2004 Aug 6;15(11):1751-4
references.pmid: 15257141
references.citation: Neurobiol Aging. 2005 Jul;26(7):995-1000
references.pmid: 15748777
references.citation: Arch Pathol Lab Med. 1993 Feb;117(2):132-44
references.pmid: 8427562
references.citation: J Gerontol A Biol Sci Med Sci. 2004 May;59(5):405-7
references.pmid: 15123747